Quinacrine-Capecitabine Combinatorial Therapy for Advanced Stage Colorectal Adenocarcinoma
Clinical trial NCT01844076 · TERMINATED
Trial details
- NCT number
- NCT01844076
- Sponsor
- Fox Chase Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-14
- Primary completion
- 2019-08-09
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.